• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一例鼻咽部未成熟PIT1谱系垂体神经内分泌肿瘤

A Case of an Immature PIT1-Lineage Pituitary Neuroendocrine Tumor of the Nasopharynx.

作者信息

Peters Jessica, Gryn Oscar, Gerka-Stuyt John

机构信息

Microbiology and Immunology, Des Moines University, Des Moines, USA.

Otolaryngology - Head and Neck Surgery, Western Reserve Hospital, Cuyahoga Falls, USA.

出版信息

Cureus. 2023 Sep 10;15(9):e44985. doi: 10.7759/cureus.44985. eCollection 2023 Sep.

DOI:10.7759/cureus.44985
PMID:37701167
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10493170/
Abstract

Pituitary neuroendocrine tumors (PitNETs) located in the nasopharynx are a rare occurrence. This case report highlights a case of a 64-year-old female diagnosed with a PitNET incidentally found in her nasopharynx. The tumor was initially seen on MRI, excised, and analyzed with immunohistochemistry, ultimately confirming an immature pituitary-specific positive transcription factor 1 (PIT1)-positive-lineage pituitary neuroendocrine tumor. The tumor contained thyrotropes, somatotrophs, and lactotrophs expressing thyroid stimulating hormone, growth hormone, and prolactin, respectively. These tumors have the potential to exhibit aggressive behavior and can disrupt the surrounding tissue. Furthermore, they can be clinically silent or, conversely, secrete multiple hormones, causing hyperthyroidism, hyperprolactinemia, and acromegaly. For these reasons, they are deemed high risk. Treatment includes surgical excision with or without anti-hormone medications prior to surgery. Medications such as somatostatin analogs are used to decrease tumor size and reduce excessive hormone excretion.

摘要

位于鼻咽部的垂体神经内分泌肿瘤(PitNETs)较为罕见。本病例报告着重介绍了一名64岁女性,其鼻咽部偶然发现患有PitNET。该肿瘤最初通过磁共振成像(MRI)发现,随后切除并进行免疫组织化学分析,最终确诊为未成熟的垂体特异性阳性转录因子1(PIT1)阳性谱系垂体神经内分泌肿瘤。肿瘤包含分别表达促甲状腺激素、生长激素和催乳素的促甲状腺细胞、生长激素细胞和催乳素细胞。这些肿瘤有可能表现出侵袭性,破坏周围组织。此外,它们在临床上可能无症状,或者相反,分泌多种激素,导致甲状腺功能亢进、高催乳素血症和肢端肥大症。因此,它们被视为高风险肿瘤。治疗方法包括手术切除,术前可使用或不使用抗激素药物。生长抑素类似物等药物用于缩小肿瘤大小并减少过量激素分泌。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/151e/10493170/dc418ac1eb94/cureus-0015-00000044985-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/151e/10493170/78146a223982/cureus-0015-00000044985-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/151e/10493170/dc418ac1eb94/cureus-0015-00000044985-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/151e/10493170/78146a223982/cureus-0015-00000044985-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/151e/10493170/dc418ac1eb94/cureus-0015-00000044985-i02.jpg

相似文献

1
A Case of an Immature PIT1-Lineage Pituitary Neuroendocrine Tumor of the Nasopharynx.一例鼻咽部未成熟PIT1谱系垂体神经内分泌肿瘤
Cureus. 2023 Sep 10;15(9):e44985. doi: 10.7759/cureus.44985. eCollection 2023 Sep.
2
Multilineage Pituitary Neuroendocrine Tumors (PitNETs) Expressing PIT1 and SF1.表达 PIT1 和 SF1 的多谱系垂体神经内分泌肿瘤(PitNETs)。
Endocr Pathol. 2023 Sep;34(3):273-278. doi: 10.1007/s12022-023-09777-x. Epub 2023 Jun 2.
3
Overview of the 2022 WHO Classification of Pituitary Tumors.《2022 年世卫组织垂体肿瘤分类概述》。
Endocr Pathol. 2022 Mar;33(1):6-26. doi: 10.1007/s12022-022-09703-7. Epub 2022 Mar 15.
4
The clinical presentation of PIT1 positive pituitary neuroendocrine tumor immunonegative for growth hormone, prolactin, and thyroid stimulating hormone with analysis of clinical and immunostaining dissociation.PIT1 阳性、生长激素、泌乳素和促甲状腺激素免疫阴性的垂体神经内分泌肿瘤的临床表现,并分析临床与免疫染色分离现象。
Clin Neurol Neurosurg. 2024 Jan;236:108075. doi: 10.1016/j.clineuro.2023.108075. Epub 2023 Nov 30.
5
Reassessment of Plurihormonal Pituitary Adenomas/PitNETs.多激素垂体腺瘤/垂体神经内分泌肿瘤的重新评估
Am J Surg Pathol. 2024 Dec 1;48(12):1600-1616. doi: 10.1097/PAS.0000000000002306. Epub 2024 Sep 5.
6
[Plurihormonal PIT1-lineage pituitary neuroendocrine tumors: a clinicopathological study].[多激素PIT1谱系垂体神经内分泌肿瘤:一项临床病理研究]
Zhonghua Bing Li Xue Za Zhi. 2023 Oct 8;52(10):1017-1024. doi: 10.3760/cma.j.cn112151-20230216-00137.
7
Pituitary neuroendocrine tumors with PIT1/SF1 co-expression show distinct clinicopathological and molecular features.具有PIT1/SF1共表达的垂体神经内分泌肿瘤表现出独特的临床病理和分子特征。
Acta Neuropathol. 2024 Jan 16;147(1):16. doi: 10.1007/s00401-024-02686-1.
8
An Update on Pituitary Neuroendocrine Tumors Leading to Acromegaly and Gigantism.导致肢端肥大症和巨人症的垂体神经内分泌肿瘤的最新进展
J Clin Med. 2021 May 22;10(11):2254. doi: 10.3390/jcm10112254.
9
Synchronous Multiple Pituitary Neuroendocrine Tumors of Different Cell Lineages.同步发生的不同细胞谱系的垂体神经内分泌肿瘤。
Endocr Pathol. 2018 Dec;29(4):332-338. doi: 10.1007/s12022-018-9545-4.
10
[New pathological classification and clinical implications of pituitary neuroendocrine tumors of the 2022 WHO version].[2022年世界卫生组织版垂体神经内分泌肿瘤的新病理分类及临床意义]
Zhonghua Yi Xue Za Zhi. 2022 Dec 20;102(47):3723-3726. doi: 10.3760/cma.j.cn112137-20220417-00825.

本文引用的文献

1
Pleiomorphism plurihormonal Pit-1-positive macroadenoma with central hyperthyroidism: a rare case report and literature review.Pit-1 阳性多激素分泌垂体大腺瘤伴中枢性甲亢:罕见病例报告及文献复习。
BMC Endocr Disord. 2022 Dec 21;22(1):325. doi: 10.1186/s12902-022-01220-2.
2
Nasopharyngeal carcinoma: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up.鼻咽癌:ESMO-EURACAN诊断、治疗及随访临床实践指南
Ann Oncol. 2021 Apr;32(4):452-465. doi: 10.1016/j.annonc.2020.12.007. Epub 2020 Dec 25.
3
How to Classify the Pituitary Neuroendocrine Tumors (PitNET)s in 2020.
2020年如何对垂体神经内分泌肿瘤(PitNET)进行分类。
Cancers (Basel). 2020 Feb 22;12(2):514. doi: 10.3390/cancers12020514.
4
Clinical challenges of a co-secreting TSH/GH pituitary adenoma.促甲状腺激素/生长激素共同分泌型垂体腺瘤的临床挑战
Endocrinol Diabetes Metab Case Rep. 2019 Sep 17;2019. doi: 10.1530/EDM-19-0068.
5
A standardised diagnostic approach to pituitary neuroendocrine tumours (PitNETs): a European Pituitary Pathology Group (EPPG) proposal.标准化诊断方法在垂体神经内分泌肿瘤(PitNETs)中的应用:欧洲垂体病理学组(EPPG)的建议。
Virchows Arch. 2019 Dec;475(6):687-692. doi: 10.1007/s00428-019-02655-0. Epub 2019 Oct 2.
6
Acromegaly.肢端肥大症。
Nat Rev Dis Primers. 2019 Mar 21;5(1):20. doi: 10.1038/s41572-019-0071-6.
7
Plurihormonal Pit-1 lineage adenoma presenting as meningitis with recurrence after somatostatin analogue.多激素垂体前叶特异性转录因子1谱系腺瘤表现为脑膜炎,使用生长抑素类似物治疗后复发。
Endocrinol Diabetes Metab Case Rep. 2019 Mar 21;2019. doi: 10.1530/EDM-18-0130.
8
GATA3 immunoreactivity expands the transcription factor profile of pituitary neuroendocrine tumors.GATA3 免疫反应扩大了垂体神经内分泌肿瘤的转录因子谱。
Mod Pathol. 2019 Apr;32(4):484-489. doi: 10.1038/s41379-018-0167-7. Epub 2018 Nov 2.
9
Silent subtype 3 pituitary adenomas are not always silent and represent poorly differentiated monomorphous plurihormonal Pit-1 lineage adenomas.静默型 3 型垂体腺瘤并非总是静默的,它们代表分化不良的单型多激素分泌垂体瘤-1 谱系腺瘤。
Mod Pathol. 2016 Feb;29(2):131-42. doi: 10.1038/modpathol.2015.151. Epub 2016 Jan 8.
10
A thyrotropin-secreting macroadenoma with positive growth hormone and prolactin immunostaining: A case report and literature review.一例生长激素和催乳素免疫染色阳性的促甲状腺激素分泌型大腺瘤:病例报告及文献复习
Niger J Clin Pract. 2015 Sep-Oct;18(5):693-7. doi: 10.4103/1119-3077.158983.